Clinical trials show GLP-1 receptor agonists reduce waist circumference by approximately 13.5 cm with semaglutide after 68 weeks, with imaging studies demonstrating significant decreases in visceral adipose tissue volume
The proglucagon gene encodes a 180-amino acid precursor that, depending on the tissue-specific expression of processing enzymes, yields different active peptides: in the pancreatic alpha cells, PCSK2 processing produces glucagon
Jardiance (empagliflozin): Proven to reduce the risk of cardiovascular death and heart failure hospitalization, Jardiance remains a cornerstone therapy, especially for patients with heart failure or kidney disease
The SEMALEAN trial found lean mass declined then stabilised while handgrip strength improved by 4.5 kg and sarcopenic obesity prevalence fell from 49% to 33% over twelve months
Blum, are going beyond the scale and leaning more heavily into the potential healthspan and longevity benefits
Its especially effective for the lower face, jawline, neck, and even areas of the body experiencing laxity
